SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is seeing intense investor activity driven by a new defense contract win and significant high-volume trading that many in the community interpret as institutional accumulation. Market participants are actively debating whether these factors signal a fundamental bottom or if the stock remains vulnerable to further volatility as they await upcoming earnings.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp is trending as investors monitor a breakout attempt toward key resistance levels, with the community actively debating whether the stock represents a long-term value play or a potential short squeeze candidate. Sentiment remains polarized between bulls citing growth metrics and upward price action as signs of institutional accumulation, and skeptics who remain wary of historical volatility and price suppression.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending as investors debate whether the current price represents a strategic buying opportunity near long-term support or a continued decline fueled by competitive pressure and retail sentiment. Community discussion is sharply divided between bulls citing the long-term potential of the Pepsi distribution deal and international expansion, and bears emphasizing ongoing short interest and worries over slowing growth.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trending as positive regulatory developments, including the potential passage of the CLARITY Act and institutional adoption, fuel strong buyer momentum. Investors are actively discussing the stock's consolidation patterns and its role as a key proxy for broader crypto-market recovery.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple (XRP) is seeing intense community discussion surrounding the anticipated Clarity Act, as traders weigh potential regulatory breakthroughs against persistent price stagnation. While some investors are optimistic about institutional adoption and geopolitical shifts in crypto regulation, others remain skeptical, pointing to the asset's historical struggle to decouple from Bitcoin and overcome ongoing sell pressure.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is experiencing significant community interest and volatility following a White House executive order aimed at fast-tracking FDA reviews for psychedelic-based mental health treatments. Investors are closely monitoring the stock as it navigates a leadership transition and high-stakes Phase 3 trial enrollment, fueling speculation about its potential as an acquisition target or long-term growth play.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is generating significant buzz following the announcement of a major device leasing partnership with Apple, which has sparked intense community discussion about the company's growth potential and its broader push into becoming a comprehensive financial super app. Investors are closely monitoring the stock's momentum as they weigh the positive implications of this deal against ongoing legal developments and anticipation surrounding the upcoming earnings report.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Vicor Corp is seeing significant volatility as investors weigh strong AI-driven backlog and growth potential against concerns over licensing revenue and complex manufacturing execution. The community remains divided, with active debates centered on whether the company's power density technology will successfully capture broader AI infrastructure demand or if current valuation levels remain disconnected from near-term delivery timelines.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is seeing heightened market interest and volatility driven by its transition into full production for a major defense contract and the commissioning of critical domestic infrastructure, including a new flotation mill in Montana. The community remains focused on the company's role as a sole-source domestic supplier of antimony for U.S. national security, with ongoing debates centering on the impact of government defense spending, geopolitical tensions, and perceived short-selling pressure.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending following a significant surge in trading volume and share price movement, largely driven by institutional accumulation and investors positioning ahead of upcoming quarterly earnings. The community is actively discussing the potential for a short squeeze, the company's expanding treatment center network, and the anticipation of pivotal clinical data readouts for non-small cell lung cancer (NSCLC) later this year.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is First Trust Materials AlphaDEX ETF (FXZ) a Strong ETF Right Now?

Should You Invest in the First Trust Materials AlphaDEX ETF (FXZ)?

 ETFs in Spotlight as Trump Moves to Mobilize Defense Production Act

Trump invokes the Defense Production Act to secure phosphorus and glyphosate. MOO could gain as domestic agricultural and materials players ramp up. 

CLF Stock Rises After Cleveland-Cliffs CEO Signals Shift Toward Rare-Earths

Equity

First Trust Exchange-Traded AlphaDEX Fund - First Trust Materials AlphaDEX Fund

Neutral Sentiment

Too early to tell

Memory stocks have been under significant selling pressure in recent weeks. Is the selloff done? Cast your vote and drop your reasoning in the comments.

Is the pullback in memory stocks over? 
 
Explain your reasoning in the comments.

Current Price	$76.70
Prev Close	$75.10
Open	$76.12
Dividend Yield	N/A
50-Day Moving Average	$80.32
Beta	N/A
Avg. Volume	60,519.57
PE Ratio	N/A

52-Week High	$85.99
52-Week Low	$55.67
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

FXZFirst Trust Exchange-Traded Fund III - First Trust Materials AlphaDEX Fund

Latest FXZ News